• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Juno Lighting

Juno Lighting

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Juno ’s Investigational CAR T Cell Product Candidates JCAR018 and JTCR016 Demonstrate Encouraging Clinical Responses in Patients with B-Cell and Mesothelioma Cancers

    Juno ’s Investigational CAR T Cell Product Candidates JCAR018 and JTCR016 Demonstrate Encouraging Clinical Responses in Patients with B-Cell and Mesothelioma Cancers

  2. US Biosimilars Market Report 2016 - Analysis, Technologies & Forecasts - Key Vendors: Amgen, Celltrion, Eli Lilly - Research and Markets

    US Biosimilars Market Report 2016 - Analysis, Technologies & Forecasts - Key Vendors: Amgen, Celltrion, Eli Lilly - Research and Markets

  3. Genome Editing: $2 Billion Technologies and Global Markets Opportunity by 2020 - Research and Markets

    Genome Editing: $2 Billion Technologies and Global Markets Opportunity by 2020 - Research and Markets

  4. Companies that Have Done What Congress Won’t

    The stocks mentioned in this article be holdings in the managed portfolios of Validea Capital Management, a separate asset management firm founded by Validea.com founder John Reese. Validea Capital Management, which an SEC registered investment advisory firm and a separate company from Validea.com, ...

  5. The Top 10 Fund Value Creators and Destroyers

    Which funds generated the greatest dollar returns in 2005?

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.